BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16914027)

  • 1. Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.
    Saebø M; Skjelbred CF; Nexø BA; Wallin H; Hansteen IL; Vogel U; Kure EH
    BMC Cancer; 2006 Aug; 6():208. PubMed ID: 16914027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study.
    Skjelbred CF; Saebø M; Nexø BA; Wallin H; Hansteen IL; Vogel U; Kure EH
    BMC Cancer; 2006 Jul; 6():175. PubMed ID: 16817948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
    Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
    BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes.
    Vogel U; Nexø BA; Tjønneland A; Wallin H; Hertel O; Raaschou-Nielsen O
    Mutat Res; 2006 Jan; 593(1-2):88-96. PubMed ID: 16054657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients.
    Obtulowicz T; Swoboda M; Speina E; Gackowski D; Rozalski R; Siomek A; Janik J; Janowska B; Ciesla JM; Jawien A; Banaszkiewicz Z; Guz J; Dziaman T; Szpila A; Olinski R; Tudek B
    Mutagenesis; 2010 Sep; 25(5):463-71. PubMed ID: 20534734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 expression is increased in colon adenoma and carcinoma and correlates with OGG1.
    Dziaman T; Ludwiczak H; Ciesla JM; Banaszkiewicz Z; Winczura A; Chmielarczyk M; Wisniewska E; Marszalek A; Tudek B; Olinski R
    PLoS One; 2014; 9(12):e115558. PubMed ID: 25526641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer.
    Hansen R; Saebø M; Skjelbred CF; Nexø BA; Hagen PC; Bock G; Bowitz Lothe IM; Johnson E; Aase S; Hansteen IL; Vogel U; Kure EH
    Cancer Lett; 2005 Nov; 229(1):85-91. PubMed ID: 15946795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
    PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ABCB1 gene expression is an early event in colorectal carcinogenesis.
    Andersen V; Vogel U; Godiksen S; Frenzel FB; Sæbø M; Hamfjord J; Kure E; Vogel LK
    PLoS One; 2013; 8(8):e72119. PubMed ID: 23977225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
    Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.
    Liu AY; Liu DG; Du YJ; Pei FH; Yang G; Liu BR; Zhang HT; Wang XH; Fan YJ; Chen YZ; Jiang Y; Chen J
    Cancer Biol Ther; 2014 May; 15(5):489-95. PubMed ID: 24521741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An association selected polymorphisms of XRCC1, OGG1 and MUTYH gene and the level of efficiency oxidative DNA damage repair with a risk of colorectal cancer.
    Przybylowska K; Kabzinski J; Sygut A; Dziki L; Dziki A; Majsterek I
    Mutat Res; 2013; 745-746():6-15. PubMed ID: 23618615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents.
    Lees NP; Harrison KL; Hall CN; Margison GP; Povey AC
    Gut; 2007 Mar; 56(3):380-4. PubMed ID: 16891355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in expression levels of ERCC1, DPYD, and VEGFA mRNA after first-line chemotherapy of metastatic colorectal cancer: results of a multicenter study.
    Baba H; Baba Y; Uemoto S; Yoshida K; Saiura A; Watanabe M; Maehara Y; Oki E; Ikeda Y; Matsuda H; Yamamoto M; Shimada M; Taketomi A; Unno M; Sugihara K; Ogata Y; Eguchi S; Kitano S; Shirouzu K; Saiki Y; Takamori H; Mori M; Hirata T; Wakabayashi G; Kokudo N
    Oncotarget; 2015 Oct; 6(32):34004-13. PubMed ID: 26372896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of AIF and caspase-3 in colorectal carcinoma, adenoma, and normal mucosa and its correlation].
    Guan JT; Wang L; Wang Y; Li Y; Wang R; Zhang WY; Zhan L; Zhou ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):391-4. PubMed ID: 19598027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of irinotecan efficacy.
    Vallböhmer D; Iqbal S; Yang DY; Rhodes KE; Zhang W; Gordon M; Fazzone W; Schultheis AM; Sherrod AE; Danenberg KD; Lenz HJ
    Int J Cancer; 2006 Nov; 119(10):2435-42. PubMed ID: 16894565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence.
    Wong JC; Hasan MR; Rahman M; Yu AC; Chan SK; Schaeffer DF; Kennecke HF; Lim HJ; Owen D; Tai IT
    Int J Cancer; 2013 Oct; 133(7):1567-77. PubMed ID: 23536448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.